ADVERTISEMENT
Aug. 23 -- ChemChina has won U.S. approval for its $43B takeover of Syngenta. That was seen as the biggest regulatory hurdle in the pursuit of this Swiss agrichemical and seed company. Bloomberg's Jonathan Browning reports on "Trending Business."
ADVERTISEMENT
RECOMMENDED FOR YOU
Star Health's Q4 Report: Post-Hike Trends Discussed With Nilesh Kambli; Multiple Banking Partnerships
Auto Sector In Focus | Ask Profit | NDTV Profit
NDTV Profit
NDTV Profit Speaks with Oppenheimer's John Stoltzfus: Future Outlook for Emerging Markets
NDTV Profit
Mutual Fund Investments: Growth Vs Value Approach | NDTV Profit
NDTV Profit
Nestle's Suresh Narayanan On Baby Food Shocker | NDTV Profit
NDTV Profit
Small & Midcap Outperformance To Reverse? | NDTV Profit
NDTV Profit
View All